Last €0.51 EUR
Change Today -0.001 / -0.20%
Volume 0.0
HXXA On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 2:08 AM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Timothy M. Sullivan Ph.D.

Vice President of Development Programs & Alliance Management, Idera Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

58$348,877
As of Fiscal Year 2012

Background*

Dr. Timothy M. Sullivan, Tim Ph.D. has been Vice President of Development Programs & Alliance Management at Idera Pharmaceuticals, Inc. (Hybridon, Inc.) since April 2010 and served as its Vice President of Development Programs from August 30, 2004 to April 2010. Dr. Sullivan serves as Senior Director, Preclinical Development since joining Hybridon, Inc. in 2002. He earned his B.S. in Microbiology from Michigan State University in 1975. His graduate studies were at Purdue ...

Read Full Background

Corporate Headquarters*

167 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-679-5500
Fax: 617-679-5592

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS 1978
Purdue University
PhD 1981
Purdue University
BS 1975
Michigan State University

Other Affiliations*

Annual Compensation*

Salary$299,000
Total Annual Compensation$299,000

Stock Options*

All Other Compensation$49,877
Exercisable Options301,124
Unexercisable Options129,876
Total Number of Options431,000

Total Compensation*

Total Annual Cash Compensation$348,877
Total Short Term Compensation$299,000
Other Long Term Compensation$49,877
Total Calculated Compensation$348,877
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HXXA:GR €0.51 EUR -0.001

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDERA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.